Pharmaids Pharmaceuticals Peer Comparison

Pharmaids Pharmaceuticals Ltd. shows significant underperformance across key financial metrics compared to its peers, with negative earnings and low efficiency ratios. The company is financially weak with high losses, low profitability, and low growth compared to industry leaders. It is positioned as a significant underperformer in the pharmaceutical sector.

• • Pharmaids has negative EPS and ROE, indicating severe financial distress.
• • The company exhibits the lowest growth metrics, with no revenue growth over three years.
• • High debt levels compared to peers and negative profit margins highlight financial instability.

• • Cipla Ltd.: Strong profitability with a PE ratio of 23.73 and an impressive EPS growth of 66.76.
• • Dr. Reddy's Laboratories Ltd.: High ROE and ROA with solid profitability metrics, ranking well in terms of financial health.
• • Mankind Pharma Ltd.: Exceptional revenue growth and solid profitability metrics, indicating strong market performance.